Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer
Triple negative breast cancer (TNBC) is an aggressive disease that is difficult to treat and portends a poor prognosis in many patients. Recent efforts to implement immune checkpoint inhibitors into the treatment landscape of TNBC have led to improved outcomes in a subset of patients both in the ear...
Main Authors: | Ashley Schreier, Roberta Zappasodi, Inna Serganova, Kristy A. Brown, Sandra Demaria, Eleni Andreopoulou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1061789/full |
Similar Items
-
Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapy
by: Roberta Zappasodi, et al.
Published: (2022-12-01) -
Ethyl Pyruvate Promotes Proliferation of Regulatory T Cells by Increasing Glycolysis
by: Ivan Koprivica, et al.
Published: (2020-09-01) -
Optimal response to tislelizumab plus chemotherapy in metastatic triple-negative breast cancer: a case report and literature review
by: Yuxin Ma, et al.
Published: (2024-03-01) -
Imunoterapia no cancro de mama triplo-negativo: o papel dos inibidores de checkpoint imunológico
by: Susana Branco, et al.
Published: (2022-11-01) -
Development and validation of a two glycolysis-related LncRNAs prognostic signature for glioma and in vitro analyses
by: Xiaoping Xu, et al.
Published: (2023-06-01)